EUVIMEDEUVIMED entdecken
Crossref

Irradiation‐Free Reduced Intensity Conditioning Stem Cell Transplantation for Young Patients With Diamond‐Blackfan Anemia Syndrome Is Well‐Tolerated and Effective

Helena Yu iD, Eric J Anderson iD, Deborah E Schiff iD, Nicholas J Gloude iD

Pediatric Blood & Cancer · 2026

DOI: 10.1002/pbc.70007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Helena Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of California San Diego, San Diego, California, USA. Hauptthemen laut MEDLINE: Anemia, Diamond-Blackfan, Transplantation Conditioning, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hematopoietic stem cell transplantation (HSCT) is a curative option for patients with Diamond‐Blackfan anemia (DBA) syndrome. Myeloablative regimens have generally been standard practice, but reduced intensity conditioning (RIC) regimens are increasingly used to minimize toxicities. We retrospectively analyzed patients with transfusion‐dependent DBA who underwent RIC HSCT with distal alemtuzumab, fludarabine, melphalan, and thiotepa at our institution. Median neutrophil engraftment was Day +15. Maximum acute graft‐versus‐host disease (GVHD) was grade II and chronic GVHD was NIH chronic moderate. All patients remain transfusion‐free with excellent donor chimerism at a median follow‐up of 52 months. HSCT with irradiation‐free RIC was well‐tolerated and effective for DBA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Diamond-BlackfanTransplantation ConditioningHematopoietic Stem Cell TransplantationHumansMaleFemaleRetrospective StudiesChild, PreschoolGraft vs Host DiseaseChildAdolescentInfantFollow-Up StudiesMelphalanVidarabineThiotepa

Stichwörter der Autor:innen

Diamond‐Blackfan anemia syndromehematopoietic stem cell transplantreduced intensity conditioning

Substanzen

MelphalanVidarabineThiotepa

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of California San Diego, San Diego, California, USA.
  • Department of Hematology/Oncology, Rady Children's Hospital San Diego, San Diego, California, USA.

ORCID-Profile: Helena Yu, Eric J Anderson, Deborah E Schiff, Nicholas J Gloude

Zitieren

APA

Yu, H., Anderson, E. J., Schiff, D. E., & Gloude, N. J. (2026). Irradiation‐Free Reduced Intensity Conditioning Stem Cell Transplantation for Young Patients With Diamond‐Blackfan Anemia Syndrome Is Well‐Tolerated and Effective. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.70007

Vancouver

Yu H, Anderson EJ, Schiff DE, Gloude NJ. Irradiation‐Free Reduced Intensity Conditioning Stem Cell Transplantation for Young Patients With Diamond‐Blackfan Anemia Syndrome Is Well‐Tolerated and Effective. Pediatric Blood & Cancer. 2026. doi:10.1002/pbc.70007

BibTeX
@article{Yu2026,
  author = {Yu, Helena and Anderson, Eric J and Schiff, Deborah E and Gloude, Nicholas J},
  title = {Irradiation‐Free Reduced Intensity Conditioning Stem Cell Transplantation for Young Patients With Diamond‐Blackfan Anemia Syndrome Is Well‐Tolerated and Effective},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  doi = {10.1002/pbc.70007}
}
Kostenlos starten →